Oppenheimer Assumes / Upgrades Questcor Pharmaceuticals (QCOR) to Outperform
Oppenheimer assumed / upgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Perform to Outperform with a price target of $57.00.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here. Shares of Questcor Pharmaceuticals closed at $47.46 yesterday, with a 52 week range of $17.25-$58.91.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here begin ad tag (tile=12) -- End ad tag --